Work

OA03 Afatinib Followed by Osimertinib in Real-World Patients with EGFR Mutation-Positive Advanced NSCLC: The Giotag Study

Year: 2018

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2018.10.013

Authors: M.J. Hochmair, A. Morabito, D. Hao, C. Yang, R. Soo, J.C. Yang, R. Gucalp, B. Halmos, A. Golembesky, A. Märten, T. Cufer

Institutions: Ludwig Boltzmann Institute for Lung Health, Otto Wagner Hospital, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", University of Calgary, Chang Gung Memorial Hospital, Taoyuan Chang Gung Memorial Hospital, Linkou Chang Gung Memorial Hospital, National University Hospital, National University Health System, National Taiwan University Hospital, Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center, Boehringer Ingelheim (Taiwan), Boehringer Ingelheim (Germany), University of Ljubljana

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2905403880

Cites:

Cited by: 1

Related to: 10